Search

Your search keyword '"Schreiber, Stefan"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Schreiber, Stefan" Remove constraint Author: "Schreiber, Stefan" Journal gut Remove constraint Journal: gut
46 results on '"Schreiber, Stefan"'

Search Results

1. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

2. A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

3. Development of an index to define overall disease severity in IBD

4. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease

5. Microbiomarkers in inflammatory bowel diseases: caveats come with caviar

7. A novel unconventional T cell population enriched in Crohn’s disease

10. Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome

11. XIAP variants in male Crohnʼs disease

12. Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.

13. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

15. Genetic factors conferring an increased susceptibility to develop Crohnʼs disease also influence disease phenotype: results from the IBDchip European Project

20. Pregnancy in primary sclerosing cholangitis

22. SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation

25. SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation.

26. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

27. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

28. Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study

29. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

30. Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

31. Development of an index to define overall disease severity in IBD

32. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).

33. Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.

34. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease

35. Development and validation of the Nancy histological index for UC

36. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

37. Geographical patterns of the standing and active human gut microbiome in health and IBD

38. Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4

39. XIAP variants in male Crohn's disease

40. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project

41. A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

42. mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn's disease

43. Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice

44. Lessons learned for clinical practice

45. A randomised phase I study of etrolizumab (rhuMAb ß7) in moderate to severe ulcerative colitis.

46. First known case of paediatric inflammatory bowel disease in a western lowland gorilla may be linked to a familial mutation in the MEFV gene.

Catalog

Books, media, physical & digital resources